Administrative Core

行政核心

基本信息

  • 批准号:
    8033334
  • 负责人:
  • 金额:
    $ 22.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

Washington University in St. Louis is an internationally known neuroscience research institution. The WUIDDRC will build on this, making existing, sophisticated methods more readily accessible to Center investigators. The University also has fundamental gaps in its research infrastructure for intellectual and developmental disabilities, and the WUIDDRC will rectify those shortcomings. Finally, the WUIDDRC will promote a collaborative, interdisciplinary environment that will accelerate research productivity in intellectual and developmental disabilities. The primary objective of the Administrative Core is to support the Center's purpose and the attainment of these objectives by two key functions - scientific leadership and Administrative supportjo ensure excellence in Core services. The first and most important is the provision of scientific leadership facilitated by the spirited exchange of ideas. The second is the management, co-ordination and administration of all Center activities. The core will support a range of leadership and Administrative functions including: 1) supporting the work of Core Directors; 2) managing the financial reporting; 3) assisting with staffing within Cores; 4) coordinating communication within the Center and with the community; 5) recruitment of new WUIDDRC investigative members; 6) managing the Center website; 7) coordinating research forums; and 8) disseminating research information throughout the Center and the greater community. All investigators within the Center will have access to the services of the Administrative Core. The scientific leadership of the Center is critical to the success of the mission of the Center. The Director, Dr. Terrie Inder, is responsible for steering the scientific course of the Center, making all budgetary decisions and coordinating WUIDDRC activities. The leadership of the Center was carefully thought through at the inception of the center. Dr. Inder was selected as the leader for the center based on the recognition of her strength as a researcher and leader by the senior members of the research community. She is dedicated to creating an environment of scientific excellence with support for facilities and personnel. She has developed strong working relationships with all the current Chairs and the Dean of the Medical School, who respect her skills and leadership. They have demonstrated their confidence in her by pledging nearly $2 million in support over the first 5 years of the new center. Dr. Inder reports directly to the Dean of the Washington University School of Medicine in matters regarding the IDDRC. She was recently promoted to Full Professor at Washington University, effective July 1st '2010. Following the first WUIDDRC submission. Dr. Inder elected to appoint a panel of Associate Directors to assist with the scientific direction of the Center and to provide broader experience in institutional leadership. She selected each Associate Director primarily on the basis of his/her research and clinical expertise to fulfill a cleariy defined role in the leadership of the Center (Table A.I). This directorship model is functioning successfully in other Research Centers within Washington University, such as the Alzheimer's Disease Research Center. Each Associate Director has been assigned leadership areas related to his/her scientific expertise. The Associate Directors review the short-term objectives and priorities of the Center with the Director via meetings or conference call for an hour every two weeks. All Associate Directors have invested in this commitment with regular meetings having commenced in December 2009. Issues to be covered at these meetings include co-ordination of seminars for the Center; challenges related to utilization and/or investigator feedback for core services; budgetary issues; and community liaison. The long-term objectives and priorities will be reviewed every six months in conjunction with the Center Management Committee (CMC). These objectives include the scientific priorities of the WUIDDRC and their attainment. Items to be covered at these meetings include review of the research productivity of the Center; methods and success in attracting new investigators; budgetary goals and outcomes; use of core services; feedback on quality from investigators; community liaison; and the integration of the WUIDDRC with other Center/Cores/Departmental services within Washington University.
位于圣路易斯的华盛顿大学是国际知名的神经科学研究机构。WUIDDRC将以此为基础,使现有的,复杂的方法更容易获得中心的调查人员。该大学在智力和发育障碍的研究基础设施方面也存在根本性的差距,WUIDDRC将纠正这些缺点。最后,WUIDDRC将促进协作,跨学科的环境,这将加快知识产权领域的研究生产力。 和发育障碍。 行政核心的主要目标是通过两个关键职能-科学领导和行政支持-支持中心的宗旨和实现这些目标,以确保核心服务的卓越。第一个也是最重要的一个方面是通过积极的思想交流提供科学的领导。第二是中心所有活动的管理、协调和行政。 核心将支持一系列领导和行政职能,包括:1)支持核心主任的工作; 2)管理财务报告; 3)协助核心内部的人员配置; 4)协调中心内部和社区的沟通; 5)招募新的WUIDDRC调查成员; 6)管理中心网站; 7)协调研究论坛;(八)研究成果传播 整个中心和更大的社区的信息。中心内的所有研究者都可以使用行政核心的服务。 该中心的科学领导对于该中心使命的成功至关重要。主任Terrie Inder博士负责指导该中心的科学进程,作出所有预算决定并协调该中心的活动。中心的领导层在中心成立之初就经过了深思熟虑。Inder博士被选为该中心的领导者,这是基于研究界高级成员对她作为研究人员和领导者的实力的认可。她致力于创造一个卓越的科学环境,为设施和人员提供支持。她与所有现任主席和医学院院长建立了牢固的工作关系,他们尊重她的技能和领导能力。他们承诺提供近200万美元的支持, 在新中心的头五年里。Inder博士直接向华盛顿大学医学院院长报告IDDRC相关事宜。她最近被提升为华盛顿大学的正教授,2010年7月1日生效。 在第一次WUIDDRC提交之后。英德博士当选任命一个副主任小组,协助中心的科学方向,并提供更广泛的机构领导经验。 她主要根据副主任的研究和临床专业知识选择副主任,以履行明确定义的中心领导职责(表A.I)。这种董事模式在华盛顿大学的其他研究中心,如阿尔茨海默病研究中心,也取得了成功。每位副主任都被分配了与其科学领域有关的领导领域, 专业知识副主任通过会议或电话会议与主任审查中心的短期目标和优先事项,每两周一小时。所有协理主任都致力于这一承诺,并于2009年12月开始举行定期会议。这些会议将讨论的问题包括中心研讨会的协调;与利用和/或研究者有关的挑战 对核心服务的反馈;预算问题;以及社区联络。长期目标和优先事项将与中心管理委员会(CMC)一起每六个月进行一次审查。这些目标包括妇女非传染性疾病研究所的科学优先事项及其实现。这些会议将讨论的项目包括审查该中心的研究生产力;吸引新的研究人员的方法和成功经验。 调查员;预算目标和成果;使用核心服务;调查人员的质量反馈;社区联络;以及WUIDDRC与华盛顿大学内其他中心/核心/部门服务的整合。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TERRIE E INDER其他文献

TERRIE E INDER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TERRIE E INDER', 18)}}的其他基金

Development and Evaluation of Diffuse Correlation Spectroscopy to Monitor Cerebral Blood Flow and Detect Intraventricular Hemorrhage in Extremely Premature Infants
漫相关光谱监测脑血流和检测极早产儿脑室内出血的开发和评估
  • 批准号:
    10468687
  • 财政年份:
    2021
  • 资助金额:
    $ 22.26万
  • 项目类别:
Development and evaluation of diffuse correlation spectroscopy to monitor cerebral blood flow and detect intraventricular hemorrhage in extremely premature infants
漫相关光谱监测脑血流和检测极早产儿脑室内出血的开发和评估
  • 批准号:
    10403869
  • 财政年份:
    2021
  • 资助金额:
    $ 22.26万
  • 项目类别:
Washington University Intellectual and Developmental Disabilities Research Center
华盛顿大学智力与发育障碍研究中心
  • 批准号:
    8018716
  • 财政年份:
    2010
  • 资助金额:
    $ 22.26万
  • 项目类别:
Washington University Intellectual and Developmental Disabilities Research Center
华盛顿大学智力与发育障碍研究中心
  • 批准号:
    8311712
  • 财政年份:
    2010
  • 资助金额:
    $ 22.26万
  • 项目类别:
Neurobehavioral Impairments in Preterm Children - A Longitudinal MR Study
早产儿的神经行为损伤——一项纵向 MR 研究
  • 批准号:
    8066229
  • 财政年份:
    2010
  • 资助金额:
    $ 22.26万
  • 项目类别:
Washington University Intellectual and Developmental Disabilities Research Center
华盛顿大学智力与发育障碍研究中心
  • 批准号:
    8118140
  • 财政年份:
    2010
  • 资助金额:
    $ 22.26万
  • 项目类别:
UNDERSTANDING NEUROBEHAVIORAL DEFICITS IN PRETERM INFANTS THROUGH IMAGING
通过影像学了解早产儿的神经行为缺陷
  • 批准号:
    7935130
  • 财政年份:
    2009
  • 资助金额:
    $ 22.26万
  • 项目类别:
Neurobehavioral Impairments in Preterm Children - A Longitudinal MR Study
早产儿的神经行为损伤——一项纵向 MR 研究
  • 批准号:
    8052886
  • 财政年份:
    2008
  • 资助金额:
    $ 22.26万
  • 项目类别:
UNDERSTANDING NEUROBEHAVIORAL DEFICITS IN PRETERM INFANTS THROUGH IMAGING
通过影像学了解早产儿的神经行为缺陷
  • 批准号:
    7350657
  • 财政年份:
    2008
  • 资助金额:
    $ 22.26万
  • 项目类别:
VENTILATION MODEL AND CNS INJURY IN BABOONS WITH BPD
BPD 狒狒的通气模型和中枢神经系统损伤
  • 批准号:
    7716070
  • 财政年份:
    2008
  • 资助金额:
    $ 22.26万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 22.26万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 22.26万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 22.26万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 22.26万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 22.26万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 22.26万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 22.26万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 22.26万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 22.26万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 22.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了